ISCT issues response to US federal judge ruling on FDA regulation of cell and gene therapies US federal judge ruling of significant concern, with widespread implications for cell and gene therapy sector as well as patient safety Vancouver, Canada, September 12, 2022 - ...
ISCT addresses manufacturing standardization, a critical issue constraining the CGT development pipeline Key insights published from ISCT 2022 Commercialization Signature Series Vancouver, Canada, September 8, 2022 - The International Society for Cell & Gene Therapy (ISCT...
ISCT & CMaT to roll out additional training programs following successful global launch of 'Workforce Development in Biomanufacturing' course The collaboration seeks to address the critical skilled labor shortage in the cell and gene therapy industry. Vancouver, Canada,...
ISCT marks bluebird bio’s landmark FDA approval a celebration for the CGT sector while calling industry to attention in the pursuit of patient access Vancouver, Canada, August 22, 2022 - The International Society for Cell & Gene Therapy (ISCT) , the global society of...
ISCT publishes conclusions and consensus from its 2022 Annual Meeting ISCT provided post-pandemic venue for the entire cell and gene therapy sector to generate solutions to the major barriers to providing therapies to patients Vancouver...
ISCT announces recipients of key 2022 achievement awards in cell and gene therapy Vancouver, Canada, April 07, 2022 - The International Society for Cell & Gene Therapy (ISCT) , the global society of clinicians, researchers,...
International Society for Cell & Gene Therapy - Ukraine Solidarity Statement As global citizens and professional clinicians, regulators, researchers, technologists and industry partners in over 60 countries on 6 continents, our ISCT values embody research, translation and clinical...
ISCT completes focus and program for 2022 Annual Meeting in San Francisco to cover cell and gene therapy ‘ Bench to Bedside to Benefit’ Annual Meeting to provide venue for the entire cell and gene therapy sector to generate solutions to its major barriers of providing therapies...